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1. Introduction 
Critically ill states, perioperative period of major surgery, particularly cardiac operations are 
often encountered with large hemodynamic alterations and fluid shifts. Cardiac failure in 
patients with congenital heart defect has heterogeneous origin therefore diagnosis related 
treatment is difficult to apply. During the postoperative period, hemodynamic instability 
has multifactorial origin and cardiorespiratory dysfunction has several manifestation e.g. 
myocardial dysfunction, pulmonary hypertension etc (Laussen & Roth, 2003). 
Biochemical markers play an important role in the risk stratification of patients with 
cardiovascular disease. Elevated brain natriuretic peptide level has been shown to reveal 
congestive heart failure among adult patients admitted to emergency department with 
dyspnoe (Maisel et al, 2002; de Lemos et al, 2001), and to predict adverse events in acute 
coronary syndromes (de Lemos et al, 2001). Cardiac troponin, creatine kinase-MB, brain 
natriuretic peptide and C-reactive protein have been shown to predict mortality and 
morbidity in unstable coronary artery disease (Lindahl et al, 2000). In patients with 
pulmonary embolism, brain natriuretic peptide and other cardiac markers, such as troponin 
predict adverse outcomes much more accurately than any other clinical signs (Kucher et al, 
2003). In the last decade, several papers investigating the prognostic, diagnostic and 
therapeutic relevance of natriuretic peptides in the pediatric population have been 
published (in rev. Cantinotti et al, 2011; Cantinotti et al, 2011). 
2. Physiology of the natriuretic peptides 
The natriuretic peptides are a family of peptides produced by the myocardium, vascular 
endothelium and the kidneys (Clerico et al, 2006). The “hormone” of the heart is involved in 
the regulation of intravascular homeostasis, myocardial function. On the other hand, 
natriuretic peptides counteract with the renin-angiotensin-aldosterone system, symphathetic 
nervous system, vasopressin release. Receptors of natriuretic peptides are mainly presented 
in the myocardium, kidneys, lungs and vascular endothelium. The action is mediated by c-
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GMP, the cytoplasmatic calcium availability will be decreased in the smooth muscles and it 
will result in vasodilatation.(Silberbach & Roberts, 2001).  
Atrial stretching triggers release of the preformed prohormone of atrial natriuretic peptide 
(NT-proANP) in the atrial wall. During secretion, the prohormone of atrial natriuretic 
peptide (ANP) is cleaved to atrial natriuretic peptide and N-terminal pro-atrial natriuretic 
peptide (Kangawa et al, 1984). Although brain natriuretic peptide chemically resembles 
atrial natriuretic peptide to some extent, it is synthetized both in the atrial and ventricular 
myocardium due to volume and pressure overload. The production of BNP requires time (6-
12 hours), since RNA transcription of the prohormone precedes the secretion. Then, the 
prohormone of brain natriuretic peptide is cleaved to brain natriuretic peptide (BNP) and N-
terminal pro-brain natriuretic peptide (NT-proBNP). N-terminal peptides have several times 
higher concentrations and longer half life time in blood circulation than atrial natriuretic 
peptide and brain natriuretic peptide, making them reliable markers (Ham et al, 1995).  
3. Diagnostic application of the natriuretic peptides 
3.1 Adult population  
In adults, diastolic dysfunction or asymptomatic aortic stenosis confirmed by 
echocardiography or angiography show marked correlations with brain natriuretic peptide 
(Gerber et al, 2003). Right-sided heart failure or complications after pulmonary embolism 
can accurately be detected by measuring natriuretic peptides, though the cut-off levels were 
only half of those for left ventricular dysfunction (Kucher et al, 2003). There are two widely 
accepted area for BNP testing; exclusion of non-cardiac origin of dyspnoe in emergency 
settings and prognostic information of various states of heart failure. NT-proBNP above 
1065 pmol/l had a very high specificity and sensitivity for cardiac failure in our population, 
similar levels were found in decompensated heart failure, septic shock and acute pulmonary 
embolism with New York Heart Association III and IV symptoms (Seino et al, 2004). 
Additionally, lower postoperative cut-off value (513 pmol/l) bore high negative predictive 
power, indicating a level below which the occurrence of heart failure is unlikely. In these 
cases, NT-proBNP or BNP measurements are used. Levels above the cut-off level were 
independently associated with increased risk for mortality and cardiovascular morbidity 
including cardiac fibrillation. In adults, it has been shown that hyperthyroidism increases 
the NT-pro BNP level and could reflect cardiac dysfunction secondary to thyreotoxicosis 
[Kato 2008, Welisch 2011]. 
ANP or NT-proANP reflect acute changes in atrial wall stress (Ruskoaho, 2003). Therefore, it 
is not suitable for long-term follow-up of congestive heart failure. Recently, a new 
immunoassay has been developed for a hybrid peptide (referred to as NT-proXNP) 
containing peptide sequences from both NT-proANP and NT-proBNP (Ala-Kopsala et al, 
2005). This novel assay mimics the physiological signaling pathway since the actions of the 
different active natriuretic fragments on the target cells are mediated by a single natriuretic 
peptide receptor. The NT-proXNP assay measures the concentration of the new virtual 
natriuretic peptide, and thus provides combined information about the plasma levels of NT-
proANP and NT-proBNP. In cardiac diseases, the neurohormonal system of the heart is 
activated. The diagnostic performances of NT-proXNP in adults for coronary artery disease 
and valvular heart disease are greater than or equal to those of NT-proANP or NT-proBNP, 
individually. NT-proXNP seems to combine the characteristics of the two natriuretic 
peptides. Therefore, NT-proXNP will increase earlier during myocardial wall stress than the 
NT-proBNP alone.  
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Fig. 1. Refence mean and median values of healthy subjects 
3.2 Pediatric population 
Based on physiological considerations, BNP and NT-proBNP levels are age dependent in the 
first two weeks after birth (Albers et al, 2006-Schwachtgen et al, 2005). The perinatal 
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transition from fetal to neonatal circulation is accompanied by an increase in the pulmonary 
blood flow and an increase in the systemic vascular resistance. These hemodynamic changes 
lead to pressure and volume load of the heart and it may stimulate the secretion and release 
of natriuretic peptides. From 31 days to 12 years of age, there is no significant change in 
healthy subjects (Cantinotti et al, 2010). From 14 years of age, gender related differences 
should be accounted and it is probably due to steroid sex hormones (Soldin et al, 2006). Age-
corrected brain natriuretic peptide and NT-proBNP values should be used in the neonatal 
population (Cantinotti et al, 2010b), while gender should be considered in the adolescent 
population. Additionally, it is important to note that reference ranges, decision values are 
method dependent and it shows variations between the assays and consequently between 
the studies (Soldin et al, 2006, Cantinotti et al, 2010). These variations are seen in Figure 1. 
As in the adult population NT-proBNP is significantly higher in children with sepsis. In 
children with sepsis NT-proBNP levels are higher in some patients with leftventricular 
dysfunction (Fried 2006). In comparison to the adult population there are no paediatric 
studies in hyperthyroidism available at present (Welisch 2011). 
3.3 Pediatric population – Congenital heart disease 
Different requirements have been formulated for the natriuretic peptide assays in the 
pediatric population. One major area is the exclusion of cardiovascular disease particularly 
below one year of age. The clinical signs are poor or share the ones with other noncardiac 
diseases. The major symptoms are dyspnea, tachypnea, cold extremities, murmurs, 
tachycardia, hypotension, etc. The assay is easy to carry out and requires only 0.5 ml blood. 
The recent studies showed convincing results that the BNP test could be performed without 
difficulties from capillary stick and it had a high negative power both in neonates and 
infants (Law et al, 2009,Maher et al, 2008). 
The anatomy of the congenital heart diseases is heterogenous. Additionally, the situation 
after different types of surgery complicates the hemodynamic state. An arbitrary 
classification is the following: ventricle volume overload, including left-right shunts, 
ventricular septal defects, patent ductus arteriosus, atrial septal defect, atrioventricular 
malformations, truncus arteriosus, etc; pressure overload, as a consequence of outflow tract 
obstruction or valvular stenosis, such as tetralogy of Fallot, pulmonary or aorta stenosis; 
univentricular physiology and non-clusterable complex malformations. Despite the age 
related BNP elevation in the neonatal period, the severity of heart failure can be determined 
and diagnosed (Cantinotti et al, 2010b, Law et al, 2009). Other studies have been described 
the linear relationship between BNP or NT-proBNP levels and the magnitude of left-right 
shunting (Kunii et al, 2003) and BNP levels were able to predict the need for ductus 
arteriosus closure (Paul et al, 2009). Echocardiographic studies have been confirmed the 
association between pressure gradient and natriuretic peptide levels (Cowley et al, 2004). In 
right sided pressure overload, the BNP levels were lower compared to left sided pressure 
overload (Cantinotti et al, 2009, Holmgren et al, 2005). In Table 1 and 2 pediatric studies 
measuring BNP and NT-proBNP levels are shown. 
3.4 Pediatric cardiac population postoperative period 
Monitoring of cardiac output is still a problematic issue, although early recognition of 
hemodynamic complications is essential in pediatric critical care. During the postoperative 
period, hemodynamically unstable patients are characterized by high volume intake, the 
need for considerable inotropic support, edema formation, hepatic congestion, lung  
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Author Key words n result 
Congenital 
HD 
cut-off// 
lowest 
level 
Lowenthal, A 
(Lowenthal 
2010) 
BNP, pediatric Carvedilol 
trial, heterogenous subject 
population, cut off values 
in subgroups
29 positive predictive of heart 
failure 
single ventricle 
physiology 
>30pg/ml 
Hall, EK (Hall 
2011) 
orthotope heart 
transplantation, follow up, 
cardiac catheterization, 
acute cellular rejection
62 Corr betw BNP&right sided 
pressure measurements 
OHT mean 
171pg/ml 
Shah A (Shah 
2009) 
single ventricle, heart 
failure, BNP
29 Positive  predictive of heart 
failure
single ventricle 
physiology
>30pg/ml 
Cowley C 
(Cowley 2004) 
catherization, BNP 
correlation pressures 
espec left ventr outflow 
obstruction
107 BNP correlates with left 
ventricular outflow 
obstruction 
median 
19pg/ml 
Muta H (Muta 
2002) 
catherization, ASD closure 14 natriuretic peptides may reflect 
hemodynamic changes
ASD ANP 24ng/l, 
BNP23ng/l 
Hsu J (Hsu 2007) neonates, cardiac surgery 36 in neonates BNP predicts 
poor outcome after cardiac 
surgery
group 1: stage 1 
Norwood,group 2: 
biventricular repair 
 
Hsu J (Hsu 2008) bidirectional 
cavopulmonary 
anastomosis, total 
cavopulmonary 
connection
36 BNP predicts unplanned 
surgical/transcatheter 
interventions includ 
transplantation 
functionally single 
ventricle 
BNP>500pg
/ml 
Knirsch W 
(Knirsch 2011) 
BNP, PulmHT, AqHD, 
CongHD 
522 BNP useful as follow-up, e.g. 
BNP decrease after Fontan 
proc, e.g. BNP decrease after 
initialization of treatment for 
PulmHT
yes (heterogeneous 
group before med 
treatment,surgery or 
catherization) 
no cut-off 
values  
Berry J (Berry 
2008) 
single ventricle, 
prognostic BNP 
25 early postoperative BNP levels 
correlate with ensuing 
duration of hospitalization and 
duration of inotropic support 
single ventricle to 
undergo Norwood, 
Bidirectional 
cavopulmonary 
Anastomosis, Fontan 
 
Law Y (Law 
2009) 
BNP, rapid triage tool, 
identify CardVascDisease
100 BNP reliable test to diagnose 
significant structural or 
functional CVD in children 
BNP: neonatal 
170pg/ml, 
older age 
41pg/ml, 
combined 
group 
44pg/ml 
Maher K (Maher 
2008) 
acute care setting, 
CongHD, AqHD 
103 BNP in acute care settings 
valuable diagnostic tool 
yes, (heterogenous 
group of 33 
children)no 
highest 
median in 
hypoplastic 
left heart 
syndr 
4920pg/ml 
El-Khuffash, A 
(El-Khuffash 
2011) 
PDA, 
neurodevelopmental 
outcome, cTNT,preterm
60 possibl assoc cTNT/BNP & 
hd significant PDA: no 
statistic significance foud
exclusion criteria 1664vs9209p
mol/lNT-
proNBNP 
Table 1. Usefulness of Brain Natriuretic Peptide measurements. Prospective observational 
study PO, Brain natriuretic peptide BNP, Atrial natriuretic peptide ANP, cardiac Troponin 
cTNT, orthotope heart transplantation OHT, persistent Ductus arteriosus PDA, Atria 
septum defect ASD, pulmonary hypertension pulmHT, aquired heart disease AqHD, 
congenital heart disease congHD, cardiovascular disease CardVascDis.  
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Author Key words n Result 
Congenital 
HD 
Cut-off// 
lowest level 
Special 
remarks 
Heise G 
(Heise 2008) 
serial, natriuretic 
hormone system, pulsatile 
MCS (Berlin Heart 
EXCOR) 
19 serial NP correlate 
with level of 
unloading of heart 
& potential recovery
15 DCM, 2 
myocarditis, 1 
CongHD, 1 Cardiac 
arrest in rejection 
after HTX 
250pg/ml  
on MCS 
none 
Gessler P 
(Gessler 
2006) 
risk stratification for low-
risk surgery in CongHD, 
RACHS-1 score, lactate, 
duration of CBP, cyanotic 
defect 
40 high NT-proBNP 
preop predictive of 
postop prolonged 
need for inotropic 
therapy 
obstructive 
lesions/ l-r-shunt/ 
cyanotic defects 
 risk 
stratificati
on for 
surgery in 
CongHD 
Pietrzak R 
(Pietrzak 
2009) 
Fallot correction, rigth 
ventricular failure, 
transannular patch, 
duration of QRS 
20 high NT-proBNP 
may help identify 
patients at risk for 
arythmias, rigth 
ventr failure after 
Fallot correction 
postop correction 
of Fallot tetralogy 
18fmol/l NT-
proBNP 
higher 
after TOFl 
correction  
Breuer T 
(Breuer 
2010) 
NT-proXNP, 
neonates/infants <1 year, 
complete biventriculair 
repair 
26 NT-proXNP 
correlates with CI 
biventriculair 
repair, <1year 
NT-proXNP 
3079pmol/l or 
NT-proBNP 
2051pmol/l 
~CI<3l/min/m2 
none 
Kaneko K 
(Kaneko 
2011) 
kawasaki syndrome,NT-
proBNP, coronary arterial 
lesions 
43 risk to develop 
coronary artery 
lesions 10x higher 
with NT-
proBNP>1000pg/ml
 NT-
proBNP>1000pg
/ml 
none 
Joseph L 
(Joseph 
2010) 
Bronchopulmonarydyspla
sia,natriureticpeptides,pre
maturity <34weeks gest 
34 NT-proBNP signif 
higher with BPD, 
NT-signif higher 
with Resp Distress 
Syndr 
Cong HD/ sepis/ 
current PDA 
exclusion criteria 
 none 
Mazurek B 
(2009) 
idiopathic ventricular 
arrhythmia, 
asymptomatic circulatory 
failure 
36 NT-proBNPincreases 
with malignant 
ventricular 
arrhythmia 
none,idiopathic 
ventricular 
arrhythmia 
66pg/ml median 
in group malign 
arryhthmia 
none 
Rusconi P 
(Rusconi 
2010) 
dilated cardiomyopathy 
(idiopathic, anthracycline-
related, uremic, muscular 
dystrophy), heart failure, 
changes in 
echocardiographic 
evalutaion of HF 
36 serial NT-proBNP 
>1000pg/ml 
correlates with HF, 
echodardiographic 
measures correlate 
with NT-proBNP 
changes within 
patients 
none NT-
proBNP>1000pg
/ml; NT-proBNP 
<450pg/ml 
asymptomatic 
patients;  
retrospect
ive 
;NT-
proBNP 
<450pg/
ml  
Nir A (Nir 
2009) 
reference values 
neonates/infants, log-
normal distribution, high 
NT-proBNP in pubertal 
girls 
690 reference values 
for pediatr 
population 
no, no cardiac 
disease, no 
respiratory disease
see table 1 combined 
study 
data 
Cohen S 
(Cohen 
2005) 
differenciate between 
cardiac or respiratory 
problem 
48 BNP differentiates 
between heart 
failure and lung 
disease, BNP for 
monitoring 
treatment for heart 
failure 
yes (heterogeneous 
group) 
2940pg/ml none 
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Author Key words n Result 
Congenital 
HD 
Cut-off// 
lowest level 
Special 
remarks 
Mir T (Mir 
2002) 
establish normal age-
related NT-proBNP levels 
in children form infant to 
adulthood, compare 
CongestiveHF with 
controlgrou 
164 NT-proBNP is 
higher in children 
with CHF, 
correlates with 
severity of clinical 
signs and 
echocardiographic 
EF 
yes, (heterogenous 
group of 31 
children) 
no none 
Wong D 
(Wong 2011) 
mechanical circulatory 
support, transplantation, 
acute decompensated 
heart failure 
24 signif diff 
MCS/no-MCS, but 
not predictive 
4 CHD, 17 
cardiomyopathy, 3 
"other" 
Median of max 
value 40pg/ml 
none 
Table 2. Usefulness of NT-proBrain Natriuretic Peptide measurements. Retrospective study 
r, n-terminal pro-brainnatriureticpeptide NT pro-BNP, brain natriuretic peptide BNP, 
dilated cardiomyopathy DCM, congestive heart failure congestiveHF, mechanical 
circulatory support MCS; cardiopulmonary bypass CPB, total corretion of Fallot TOF, 
persistent Ductus arteriosus PDA, Risk Adjustement for Congenital Heart Surgery RACHS-
1 (Jenkins 2004) 
dysfunction or the combination of them (Laussen & Roth, 2003). High lactate levels and low 
base excess on the first postoperative day have been reported to predict mortality and 
outcome in pediatric cardiac patients (Tibby et al, 1999, Carmona et al, 2008). Mir et al.found 
limited value of NT-proBNP levels in the perioperative period. In their study, dosage and 
duration of catecholamines and length of mechanical ventilation correlated with 
postoperative troponin T and arterial lactate levels, but not with NT-proBNP (Mir et al, 
2006). Since catecholamine therapy is a consequence of hemodynamic instability and 
prolonged mechanical ventilation can be influenced by certain non-cardiac factors, the direct 
relationship might be concerned. Indeed, clinical signs and scores of congestive heart failure 
is difficult to apply as diaphoresis, respiratory rate, heart rate in the early postoperative 
period are strongly modified by inotropic, analgesic and sedative medication (Tibby et al, 
1999). Preoperative NT-proBNP was associated with adverse postoperative outcome in 
children undergoing heart surgery, like duration of mechanical ventilation, dose of inotropic 
support, length of intensive care unit stay (33-Hsu et al, 2007). BNP and NT-proBNP levels 
usually exceed the peak maximum at 12 hours, and a second peak may occur about five 
days after surgery (Koch et al, 2007). Postoperative BNP and NT-proBNP levels have also 
been shown to have prognostic value after pediatric cardiac surgery. After cavopulmonary 
anastomosis a decrease in natriuretic peptides level compared to preoperative level were 
correlated with better outcomes (Hsu et al, 2008). Prognostic role of BNP was also reported 
after switch surgery in neonates (Lehot et al, 1992). 
Our study investigated the prognostic role of NT-proXNP, a hybride analyte. NT-proXNP 
level correlated significantly with the simultaneously measured NT-proANP level (r = 0.60, 
p < 0.001), but more strongly with NT-proBNP level (r = 0.89, p < 0.001) and the arithmetic 
sum of both peptides throughout the perioperative period (r = 0.88, p < 0.001). Baseline NT-
proXNP level correlated with the age (r = -0.72, p < 0.001) and the weight of the patients (r = 
-0.47, p = 0.026). Preoperative creatinine level (53.3 ± 13.1 μmol/l) correlated with baseline 
NT-proXNP (r = 0.53, p = 0.013). The duration of operation and the duration of CPB were 
associated with the preoperative NT-proXNP level (r = 0.58, p = 0.005 and r = 0.62 p = 0.002, 
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Fig. 2. Correlation between logarithmic transformed NT-proXNP levels and 
cardiopulmonary bypass time 
respectively) and the peak postoperative NT-proXNP level (r = 0.64, p < 0.001 and r = 0.67,  
p < 0.001, respectively). NT-proBNP showed similar correlations with the duration of 
operation and CPB (Breuer et al, 2010). In the postoperative period, natriuretic peptide 
levels correlated significantly with the simultaneously assessed hemodynamic parameters. 
NT-proXNP correlated stronger with the hemodynamic parameters except for extravascular 
lung water index than the arithmetic sum of NT-proANP and NT-proBNP. The correlation 
between NT-proXNP and CI remained significant after adjusting for age (r = 0.60, p = 0.018) 
or weight (r = 0.81, p < 0.001). 
The hemodynamic parameters improved during the postoperative period as the 
myocardium recovered. The application of transpulmonary thermodilution was safe and 
reliable and it added useful information to the conventionally measured pressure values in 
neonates and infant following open heart surgery. We found lower global enddiastolic 
volume indices and higher extravascular lung water indices compared to adult ranges, 
whereas the cardiac indices were the same. Age related and disease specific reference values 
of the transpulmonary thermodilution parameters are yet to be determined in children. 
In ROC analysis, a postoperative NT-proBNP level of 2051 pmol/l was diagnostic for 
cardiac index (CI) lower than 3 l/min/m2 with 79% sensitivity and 95% specificity (AUC: 
0.87 ± 0.06), whereas a postoperative NT-proXNP level of  079 pmol/l was diagnostic for 
that with 89% sensitivity and 90% specificity (AUC: 0.91 ± 0.05). The length of mechanical 
ventilation and ICU stay did not correlate with the baseline or the peak natriuretic peptide 
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levels. NT-proBNP and NT-proXNP, but not NT-proANP level at 24 hours after surgery 
were correlated to the length of mechanical ventilation (r = 0.51, p = 0.015 and r = 0.47, p = 
0.027, respectively). The area under the curve (AUC) of NT-proBNP and NT-proXNP at 24 
hours after surgery for prolonged mechanical ventilation (> 72h) in ROC analysis was 0.81 ± 
0.10 and 0.72 ± 0.11, respectively. 
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Fig. 3. Relationship between logarithmic transformed NT-proXNP levels and Cardiac index  
Conventionally measured parameters such as heart rate, mean arterial pressure and pulse-
pressure product exhibited weaker correlations with CI than natriuretic peptide levels. 
Parameters measured by echocardiography i.e. fractional shortening and calculated 
pressures of the right ventricle were not correlated to CI. Clinical and laboratory values, 
except for creatinine level and creatinine clearance, showed no correlation with CI or NT-
proXNP. According to our findings, natriuretic peptides and NT-proXNP are indicators of 
hemodynamic parameters following pediatric cardiac surgery that can only be measured by 
invasive hemodynamic monitoring. 
3.5 Pediatric cardiac population–follow-up period 
Pediatric cardiac population follow-up period Pediatric patients with simple cardiac lesions 
after corrective surgery show a marked reduction in BNP and NT-proBNP levels compared 
to the preoperative period. The same is true after catheter interventions, like closure of atrial 
r = 0,67  
p < 0,001 
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septal defect or closure of ductus arteriosus. In patients with residual defects, like 
pulmonary stenosis or pulmonary arterial hypertension, serial measurements of BNP or NT-
proBNP levels provide a useful, easy and non-invasive tool for follow-up and it can be used 
for quantification of the disease severity. During the follow-up of cardiac transplant patients 
rejection can be detected by increase of BNP levels. 
4. Conclusion 
Natriuretic peptide levels are age dependent and show significant variability according to 
the type of the cardiac malformation and the actual hemodynamic condition. Recently, age 
related normal values have been established in the neonatal period and it allows detection 
of the congental heart disease in different age groups. Right sided hemodynamic ventricular 
stress is encountered with lower BNP values. Preoperative and postoperative application of 
natriuretic peptides provides a useful tool for the detection of postoperative complications. 
The new analyte, NT-proXNP seems to have promising characteristics, because it reflects the 
cardiac output changes earlier than the BNP, NT-proBNP assay.  
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